An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer

British Journal of Cancer

Volumn 107, Issue 1, 2012, Pages 123-128

  Miah, S ^a   Dudziec, E ^a   Drayton, R M ^a   Zlotta, A R ^b   Morgan, S L ^c   Rosario, D J ^a   Hamdy, F C ^d   Catto, J W F ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b MOUNT SINAI HOSPITAL   (Canada)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

bladder cancer; MicroRNA; urine

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 100; MICRORNA 1224; MICRORNA 1224 3P; MICRORNA 135B; MICRORNA 15A; MICRORNA 15B; MICRORNA 203; MICRORNA 212; MICRORNA 24 1; MICRORNA 27B; MICRORNA 328; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84862985163     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.221     Document Type: Article

References (25)

1. Avritscher EB, Cooksley CD, Grossman HB, Sabichi AL, Hamblin L, Dinney CP, Elting LS (2006) Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 68(3): 549-553 (Pubitemid 44436509)
2. Carmack AJ, Soloway MS (2006) The diagnosis and staging of bladder cancer: from RBCs to TURs. Urology 67(3 Suppl 1): 3-8; discussion 8-10
3. Catto JW, Abbod MF, Linkens DA, Larre S, Rosario D J, Hamdy F C (2009) Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. Clin Cancer Res 15(9): 3150-3155
4. Catto JW, Abbod MF, Wild PJ, Linkens DA, Pilarsky C, Rehman I, Rosario DJ, Denzinger S, Burger M, Stoehr R, Knuechel R, Hartmann A, Hamdy FC (2010) The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression. Eur Urol 57(3): 398-406
5. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59(5): 671-681
6. Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, Fromont G, Sibony M, Cussenot O, Meuth M, Hamdy FC (2005) Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 23(13): 2903-2910 (Pubitemid 46224108)
7. Catto JW, Miah S, Owen HC, Bryant H, Myers K, Dudziec E, Larre S, Milo M, Rehman I, Rosario DJ, Di Martino E, Knowles MA, Meuth M, Harris AL, Hamdy FC (2009) Distinct microRNA alterations characterize highand low-grade bladder cancer. Cancer Res 69(21): 8472-8481
8. Dudziec E, Miah S, Choudhury HMZ, Owen HC, Blizard C, Glover M, Hamdy FC, Catto JW (2011) Hypermethylation of CpG Islands and Shores around specific MicroRNAs and Mirtrons is associated with the phenotype and presence of Bladder Cancer. Clin Cancer Res 17(6): 1287-1296
9. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhoi BP, Kjems J, Borre M, Orntoft TF (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69(11): 4851-4860
10. Guhaniyogi J, Brewer G (2001) Regulation of mRNA stability in mammalian cells. Gene 265(1-2): 11-23 (Pubitemid 32209246)
11. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, Warnecke JM, Sczakiel G (2009) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 28(6): 655-661
12. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM (2005) A microRNA polycistron as a potential human oncogene. Nature 435(7043): 828-833 (Pubitemid 40839734)
13. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60(5): 277-300
14. Johnstone DB, Holzman LB (2006) Clinical impact of research on the podocyte slit diaphragm. Nat Clin Pract Nephrol 2(5): 271-282 (Pubitemid 43787260)
15. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F, Kreipe H (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214(1): 17-24
16. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30): 10513-10518
17. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA, Agami R (2008) Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68(14): 5795-5802
18. Planz B, Jochims E, Deix T, Caspers HP, Jakse G, Boecking A (2005) The role of urinary cytology for detection of bladder cancer. Eur J Surg Oncol 31(3): 304-308 (Pubitemid 40361523)
19. Sangar VK, Ragavan N, Matanhelia S S, Watson M W, Blades R A (2005) The economic consequences of prostate and bladder cancer in the UK. BJU Int 95(1): 59-63 (Pubitemid 350020870)
20. Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS, Chen C (2008) Real-time PCR quantification of precursor and mature microRNA'. Methods 44(1): 31-38 (Pubitemid 350297984)
21. Schrier BP, Hollander MP, van Rhijn BW, Kiemeney LA, Witjes JA (2004) Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45(3): 292-296 (Pubitemid 38221401)
22. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6): 654-659 (Pubitemid 47214727)
23. Van Rhijn BW, Lurkin I, Chopin DK, Kirkels WJ, Thiery JP, van der Kwast TH, Radvanyi F, Zwarthoff EC (2003) Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine. Clin Cancer Res 9(1): 257-263 (Pubitemid 36109742)
24. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124(6): 1169-1181
25. Zwarthoff EC (2008) Detection of tumours of the urinary tract in voided urine. Scand J Urol Nephrol Suppl 218: 147-153